Relief Biotech Pvt. Ltd.

Our History :

We’ve done great things in the past. Today, we’re doing great things for the future.
Fascinating Story of Success and Excellence
Relief Biotech Pvt Ltd. Drugs & Pharmaceuticals Ltd. was incorporated on Nov. 06th, 2006. This decision of the Company was historic in more ways than one. It was to mark the beginning of a long and eventful journey into Pharmaceutical Business. Over the years Relief Biotech Pvt Ltd. has evolved from a manufacturer of few products into a fully integrated pharmaceutical company. Today, we leverage a formidable combination of manufacturing technologies and research skills to develop affordable and unmet medical needs. Relief Biotech Pvt Ltd. is professionally managed by the Board of Directors who is assisted by a team of qualified and experienced professional executives. Success does not make a Company great, what really a matter is its contribution towards making life better for everybody. Relief Biotech Pvt Ltd. is strong both technically and commercially. In its pursuit of growth with internationally accepted excellent quality healthcare products and in its flight for excellence, each achievement is a brief stopover of journey and is not a permanent destination. Growth with excellence is a continuous process of Relief Biotech Pvt Ltd.
MILESTONES :
2006
Relief Biotech Pvt Ltd. began operations in Roorkee with Beta lactum /non Beta lactum with products like tablets, hard gelatin capsules, dry syrups & liquid orals. Year 1 turnover- Rs.12 crore. Within a year, the marketing effort expands to cover all the states of India. A compact manufacturing facility for tablets/capsules was set up at Roorkee.

Mission & Vision :

Mission : “ To revolutionize the Relief Biotech Pvt Ltd. system by providing superior quality products for ultimate customer satisfaction.”.

Our Vision : “Our Vision is to become an unsurpassed pharmaceutical manufacturing company, leading the way to a healthier world. Our Vision is reflected in every department of our organization as we desire to conquer the pharmaceutical domain globally.”